Katherine Strei Emergent Bio Solutions Inc. (EBS) insider trading activity

Katherine Strei is EVP, Chief HR Officer of Emergent BioSolutions Inc.. Currently has a direct ownership of 62,824 shares of EBS, which is worth approximately $521,439. The most recent transaction as insider was on Feb 28, 2023, when has been sold 690 shares (Common Stock) at a price of $12.38 per share, resulting in proceeds of $8,542. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 62.8K

0% 3M change

0% 12M change

Total Value Held $521,439

Katherine Strei Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2023	SELL Payment of exercise price or tax liability	$8,542 $12.38 p/Share	690 Reduced 1.09%	62,824 Common Stock
Feb 24 2023	SELL Payment of exercise price or tax liability	$8,966 $13.71 p/Share	654 Reduced 1.02%	63,514 Common Stock
Feb 23 2023	SELL Payment of exercise price or tax liability	$5,033 $14.3 p/Share	352 Reduced 0.55%	64,168 Common Stock
Feb 08 2023	SELL Payment of exercise price or tax liability	$19,053 $13.25 p/Share	1,438 Reduced 2.18%	64,520 Common Stock
Feb 08 2023	BUY Grant, award, or other acquisition	-	61 Added 0.09%	65,958 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	36,250 Added 35.29%	66,458 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$22,238 $39.64 p/Share	561 Reduced 0.84%	65,897 Common Stock
Feb 24 2022	SELL Payment of exercise price or tax liability	$25,057 $42.47 p/Share	590 Reduced 1.92%	30,208 Common Stock
Feb 23 2022	SELL Payment of exercise price or tax liability	$14,527 $42.23 p/Share	344 Reduced 1.1%	30,798 Common Stock
Feb 22 2022	SELL Payment of exercise price or tax liability	$68,244 $42.23 p/Share	1,616 Reduced 4.93%	31,142 Common Stock
Feb 22 2022	BUY Grant, award, or other acquisition	-	1,258 Added 3.7%	32,758 Common Stock
Feb 26 2021	SELL Payment of exercise price or tax liability	$117,552 $97.15 p/Share	1,210 Reduced 3.7%	31,500 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$57,870 $93.49 p/Share	619 Reduced 1.86%	32,710 Common Stock
Feb 24 2021	BUY Grant, award, or other acquisition	-	5,348 Added 13.83%	33,329 Common Stock
Feb 09 2021	SELL Payment of exercise price or tax liability	$252,085 $123.45 p/Share	2,042 Reduced 6.8%	27,981 Common Stock
Feb 09 2021	BUY Grant, award, or other acquisition	-	2,014 Added 6.29%	30,023 Common Stock

Katherine Strei

EVP, Chief HR Officer

Gaithersburg, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EBS shares.

Notify only if

Value

Insider Trading

Get notified when an Emergent Bio Solutions Inc. insider buys or sells EBS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Emergent BioSolutions Inc.

Track Activities on EBS

Account